The effect of locoregional therapies in patients with advanced hepatocellular carcinoma treated with sorafenib

BACKGROUND & AIMS: It is unknown whether the addition of locoregional therapies (LRTx) to sorafenib improves prognosis over sorafenib alone in patients with advanced hepatocellular carcinoma (HCC). The aim of this study was to assess the effect of LRTx in this population. METHODS: A retrospectiv...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:HPB (Oxford)
Main Authors: Sarpel, Umut, Spivack, John H., Berger, Yaniv, Heskel, Marina, Aycart, Samantha N., Sweeney, Robert, Edwards, Martin P., Labow, Daniel M., Kim, Edward
Formato: Artigo
Idioma:Inglês
Publicado em: Elsevier 2016
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4857060/
https://ncbi.nlm.nih.gov/pubmed/27154804
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.hpb.2016.02.007
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados